Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing protein intake methods in patients with chronic kidney disease.

Official title: Assessment of Protein Intake Using 2 Types of Nutritional Collection in Comparison with 24-hour Urine Urea, in Chronic Kidney Disease.

Run by Assistance Publique Hopitaux De Marseille · NCT06224153 · Data updated 2026-11-12

This study is testing two ways to track protein intake in people with advanced chronic kidney disease to see which method helps them follow a low-protein diet better and delay the need for dialysis.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorAssistance Publique Hopitaux De Marseille
Academic / other
Locations1 site (Marseille, France)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedDecember 15, 2027
Study endsJuly 2028
Registry record updatedNovember 19, 2024
Trial IDNCT06224153 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with stage 4 or 5 chronic kidney disease who are motivated to follow a hypo-protein diet.

Probably not a fit

Patients currently undergoing dialysis or those with ongoing cancer or significant undernutrition may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates two methods for assessing protein intake in patients with chronic kidney disease (CKD) stages 4 and 5. The study compares the traditional 24-hour urine urea measurement with a detailed 3-day dietary record and Food Frequency Questionnaire (FFQ) to determine the most effective approach for introducing a low-protein diet. The goal is to better understand dietary habits and facilitate dietary modifications to delay the need for dialysis. Conducted in the PACA region of France, the study aims to improve dietary management for CKD patients.

Why it matters

Potential benefit: If successful, this study could enhance dietary management strategies for CKD patients, potentially delaying the need for dialysis.

How similar studies have gone: While the approach of assessing dietary intake is common, this specific comparison of methods in CKD patients is less explored, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient at least 18 years of age,
* Patient capable of understanding the study and having given informed non-opposition,
* Patient with stage 4 or 5 CKD,
* Patient included in the MRC pathway,
* Patient motivated by a hypo-protein diet,
* Patient able to use a computer/smartphone/tablet with Internet access.

Exclusion Criteria:

* Difficulty reading or understanding the French language,
* Patient with ongoing cancer,
* Patient undernourished or at risk of undernutrition (based on weight loss and albumin measurement from last blood test),
* Persons covered by articles L. 1121-5 to L. 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women).
* Dialysis patient
* Patient who underwent major surgery less than 3 months ago.

Where it's running

  • Centre de néphrologie et de transplantation rénale
    Marseille, France, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Primary Palliative Care: A Feasibility Project for Family Health Units

    This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.

    Recruiting University of Coimbra · Coimbra and 1 other locations · NCT07737899

  • Synbiotic capsules for adults on peritoneal dialysis

    This study tests whether daily synbiotic capsules can reduce inflammation and improve nutrition in adults with CKD on peritoneal dialysis compared with a placebo.

    Recruiting Hospital Universitario Dr. Jose E. Gonzalez · Monterrey, Nuevo León · NCT07694791

  • Potassium-friendly plant-based diet for people with advanced CKD

    This pilot study tests whether a liberal plant-based diet with normal potassium levels is safe and acceptable for adults with advanced CKD (eGFR <30) who are not on dialysis.

    Recruiting Karolinska Institutet · Huddinge, Stockholm Län · NCT07494266

  • Herbal Medicine Use in CKD Patients on Réunion Island

    This study tests how common herbal medicine use is among adults with chronic kidney disease (stages 3–5) on Réunion Island and whether it relates to kidney disease progression over a year.

    Recruiting at 4 sites Centre Hospitalier Universitaire de la Réunion · Saint-Benoît and 3 other locations · NCT07444515

  • Storing deceased donor kidneys at 10°C instead of on ice (4°C)

    This trial will try to see if deceased donor kidneys stored at 10°C help adult transplant recipients have better kidney function after transplant compared with kidneys stored on ice (4°C).

    Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT07385651

  • ACE Reno Pico Cell Matrix for reducing proteinuria and supporting kidney function

    This trial will test whether taking ACE Reno, a sublingual peptide solution four times daily for 12 weeks, can lower urine protein and help stabilize kidney function in adults with nephropathy or chronic kidney disease.

    Recruiting Phase 4 Ace Cells Lab Limited · Giza, GZ · NCT07187713

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.